TMCnet News
Biotech Showcase™ 2015 Surpasses All Previous Investor Attendance, Partnering NumbersThe seventh annual Biotech Showcase™ investor conference wrapped up the week of January 12 in San Francisco with the highest number of delegates in attendance since its founding. 
More than 2,100 executive-level delegates from 1,287 companies attended Biotech Showcase™ 2015 in San Francisco this January. (Photo: Business Wire) More than 2,100 executive-level delegates representing qualified private and public equity investors, industry analysts, bankers, pharmaceutical and biotechnology industry executives attended from 1,287 companies and participated in nearly 4,300 one-to-one investor meetings. "The positive feedback we have received about Biotech Showcase 2015 is clear evidence that it is considered a must-attend meeting by biotech, pharma, and investors and other industry executives every January," said Sara Jane Demy, CEO of Demy-Colton Life Science Advisors. "The caliber and variety of investors this year is unmatched by previous editions of Biotech Showcase which is a testament to the buoyancy of the current market." "This year we had a stellar list of 232 public and private biotech presenting companies with numerous investment opportunities," said Anna Chrisman, Group Managing Director, EBD Group. "The market is up and there is significant activity, which makes Biotech Showcase very compelling for life sciences companies looking for investors and partners." Biotech Showcase is powered by partneringONE®, the industry's most advanced meeting system that enables delegates to efficiently identify and arrange meetings with potential investors. Up-to-date coverage of Biotech Showcase, including panel videos and interviews, can be found on the Biotech Showcase website, on partnering360:Insight, and on the partnering360 Blog. The next edition of Biotech Showcase will be held January 11-13, 2016 in San Francisco. About Biotech Showcase™: Biotech Showcase™ is an investor conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attracts investors and biopharmaceutical executives from around the world. The 2015 edition showed a substantial increase in the number of presenting companies, as well as significant growth in the number of attendees and one-to-one meetings. The 2015 event featured corporate presentations by 232 public and private biotechnology and life science companies, and drew 2,161 delegates who engaged in 4,278 one-to-one meetings. Follow continuing Biotech Sowcase 2015 conversations on Twitter (News - Alert): twitter.com/ebdgroup (hashtag: #BTS15). About EBD Group EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group's partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success. EBD Group's conferences are run with the support of leading corporations and international trade associations and include:
EBD Group's sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year. EBD Group is an Informa (News - Alert) company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world. EBD Group has offices in the USA and Europe. For more information please visit www.ebdgroup.com. About Demy-Colton Life Science Advisors Demy-Colton Life Science Advisors is focused exclusively on facilitating the growth of the life science industry. Demy-Colton has developed a number of high-value added conferences to address the business and development needs of the biotechnology industry; it provides partnering services and it has helped launch a unique investor website and newsletter. Demy-Colton's conferences include:
Demy-Colton's online partnering system, Networking2™, supports Demy-Colton's events and facilitates investor and venture meetings for the pharma industry and partnering for other organizations. For more information please visit www.demy-colton.com Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20150127005993/en/ |
